Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Kevin KalinskyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Dr. Mahtani on the Use of CDK 4/6 Inhibitors in Metastatic ER+ Breast CancerПодробнее

Dr. Reshma Mahtani: Guideline Updates for Extended Endocrine Therapy Decision-MakingПодробнее

2020 Best of Breast - Reshma Mahtani, DO | Discusses Success in HER2+Подробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. CareyПодробнее

Diagnostics: Genomics for Treatment Planning | Reshma Mahtani, DO | 2022 Review and Renew SedonaПодробнее

Dr Reshma Mahtani, DOПодробнее

Combination Treatment of HER2+ Metastatic Breast Cancer: First-Line TherapyПодробнее

Determining the Duration of Aromatase Inhibitor Therapy - An Interview With Reshma MahtaniПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’ReganПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Alvaro Moreno-AspitiaПодробнее

Reshma Mahtani, DO | Sylvester Cancer | ASCO20 Breast Cancer Reactions: MINDACT for Early StageПодробнее

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Sramila Aithal, MD | Neratinib and Dose Escalation | Optimizing Therapy for HER2+ DiseaseПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. SolimanПодробнее